IGEA Pharma N.V. (SWX:IGPH) announced that it has entered into a letter of intent with an institutional investor for a convertible bond facility for gross proceeds of €10 million on March 25, 2021. The company will receive funding over the next 24 months. The transaction is expected to close within first half of April 2021.